Malovrh P - Search Results

1

A comparative outcome study of frequent, moderate, occasional, and nonattenders of Alcoholics Anonymous.

Watson CG, Hancock M, Gearhart LP, Mendez CM, Malovrh P, Raden M. Watson CG, et al. Among authors: malovrh p. J Clin Psychol. 1997 Apr;53(3):209-14. doi: 10.1002/(sici)1097-4679(199704)53:3<209::aid-jclp3>3.0.co;2-m. J Clin Psychol. 1997. PMID: 9075048

2

A comparison of the symptoms associated with early and late onset alcohol dependence.

Watson CG, Hancock M, Gearhart LP, Malovrh P, Mendez C, Raden M. Watson CG, et al. Among authors: malovrh p. J Nerv Ment Dis. 1997 Aug;185(8):507-9. doi: 10.1097/00005053-199708000-00005. J Nerv Ment Dis. 1997. PMID: 9284864

3

A 48-week natural history follow-up of alcoholics who do and do not engage in limited drinking after treatment.

Watson CG, Hancock M, Malovrh P, Gearhart LP, Raden M. Watson CG, et al. Among authors: malovrh p. J Nerv Ment Dis. 1996 Oct;184(10):623-7. doi: 10.1097/00005053-199610000-00007. J Nerv Ment Dis. 1996. PMID: 8917160

4

Diluted thrombin time reliably measures low to intermediate plasma dabigatran concentrations.

Božič-Mijovski M, Malmström RE, Malovrh P, Antovic JP, Vene N, Šinigoj P, Mavri A. Božič-Mijovski M, et al. Among authors: malovrh p. Ann Clin Biochem. 2016 Jul;53(Pt 4):446-51. doi: 10.1177/0004563215599795. Epub 2015 Sep 21. Ann Clin Biochem. 2016. PMID: 26392631

5

An individually, modified approach to desensitize infants and young children with Pompe disease, and significant reactions to alglucosidase alfa infusions.

El-Gharbawy AH, Mackey J, DeArmey S, Westby G, Grinnell SG, Malovrh P, Conway R, Kishnani PS. El-Gharbawy AH, et al. Among authors: malovrh p. Mol Genet Metab. 2011 Sep-Oct;104(1-2):118-22. doi: 10.1016/j.ymgme.2011.07.004. Epub 2011 Jul 13. Mol Genet Metab. 2011. PMID: 21802969 Free PMC article.

6

Equinatoxin II permeabilizing activity depends on the presence of sphingomyelin and lipid phase coexistence.

Schön P, García-Sáez AJ, Malovrh P, Bacia K, Anderluh G, Schwille P. Schön P, et al. Among authors: malovrh p. Biophys J. 2008 Jul;95(2):691-8. doi: 10.1529/biophysj.108.129981. Epub 2008 Apr 4. Biophys J. 2008. PMID: 18390598 Free PMC article.

7

Cytotoxic activity of a tumor protease-activated pore-forming toxin.

Potrich C, Tomazzolli R, Dalla Serra M, Anderluh G, Malovrh P, Macek P, Menestrina G, Tejuca M. Potrich C, et al. Among authors: malovrh p. Bioconjug Chem. 2005 Mar-Apr;16(2):369-76. doi: 10.1021/bc049873z. Bioconjug Chem. 2005. PMID: 15769091

8

A novel mechanism of pore formation: membrane penetration by the N-terminal amphipathic region of equinatoxin.

Malovrh P, Viero G, Serra MD, Podlesek Z, Lakey JH, Macek P, Menestrina G, Anderluh G. Malovrh P, et al. J Biol Chem. 2003 Jun 20;278(25):22678-85. doi: 10.1074/jbc.M300622200. Epub 2003 Apr 2. J Biol Chem. 2003. PMID: 12676945 Free article.

9

Two-step membrane binding by Equinatoxin II, a pore-forming toxin from the sea anemone, involves an exposed aromatic cluster and a flexible helix.

Hong Q, Gutierrez-Aguirre I, Barlic A, Malovrh P, Kristan K, Podlesek Z, Macek P, Turk D, Gonzalez-Manas JM, Lakey JH, Anderluh G. Hong Q, et al. Among authors: malovrh p. J Biol Chem. 2002 Nov 1;277(44):41916-24. doi: 10.1074/jbc.M204625200. Epub 2002 Aug 26. J Biol Chem. 2002. PMID: 12198118 Free article.

10

Structure-function studies of tryptophan mutants of equinatoxin II, a sea anemone pore-forming protein.

Malovrh P, Barlic A, Podlesek Z, MaCek P, Menestrina G, Anderluh G. Malovrh P, et al. Biochem J. 2000 Feb 15;346 Pt 1(Pt 1):223-32. Biochem J. 2000. PMID: 10657261 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results